Dec 29, 2022

The Unfortunate News About HRRP, With Insight Into How to Fix It, With Rishi Wadhera, MD, MPP (Encore! EP326)

In this Encore, Stacey Richter revisits her conversation with Rishi Wadhera, MD, MPP, a cardiologist at Beth Israel Deaconess Medical Center, about why the Hospital Readmissions Reduction Program (HRRP) may be...

Dec 22, 2022

PBM Spread Pricing on Generics, and Why GoodRx and Amazon Are Forcing a Response, With Ge Bai, PhD, CPA (Encore EP356)

How Spread Pricing Lets PBMs Profit — and Why GoodRx and Amazon Pharmacy Are Forcing a Change. Encore Episode 356.

The so-called Big Three pharmacy benefit managers — Express Scripts (ESI), OptumRx,...

Dec 15, 2022

Harnessing the Miracle of the Commons to Improve the Patient Journey Nationwide, A Conversation With Dave Dierk, Co-President of Aventria Health Group (INBW37)

Stacey Richter is joined by Dave Dierk, co-president of Aventria Health Group, to introduce Groundswell — Aventria’s framework for getting diverse healthcare...

Dec 8, 2022

Merrill Goozner on the Future of Healthcare and Glide Paths to Get There. Three Realistic Glide Paths to Rightsizing Healthcare Spending Relative to GDP. Episode 388.

Stacey Richter talks with Merrill Goozner, former editor in chief of Modern Healthcare and author of The $800 Million Pill, about three concrete glide...

Dec 1, 2022

Medicare Advantage Trends and How Medicare Advantage Plans Will or Will Not Succeed, With Betsy Seals. What Separates Medicare Advantage Plans That Succeed From Those That Flame Out. Episode 387.

Stacey Richter talks with Betsy Seals, CEO and cofounder of Rebellis Group, about the critical success factors—scale,...